Inventor · disambiguated record
Suzanne J. Suchard
Also filed as: SUCHARD SUZANNE · SUCHARD SUZANNE J · TODDERUD C GORDON
25 granted patents·8 pending applications·207 citations·filing 2000–2023
96Inventor score
Top patents by PatentIndex Score
33 records- 0196US11613585B2Nucleic acids encoding antagonistic CD40 monoclonal antibodiesBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Mar 28, 2023·3 cites·17 claims
- 0296US11220550B2Antagonistic anti-CD40 antibodies and methods of antagonizing CD40 activityBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 11, 2022·12 cites·15 claims
- 0394US8895010B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Nov 25, 2014·24 cites·36 claims
- 0493US8454959B2Compositions monovalent for CD28 binding and methods of useMCKINNON MURRAY·Filed 2012·Granted Jun 4, 2013·23 cites·11 claims
- 0593US8168759B2Compositions monovalent for CD28 binding and methods of useMCKINNON MURRAY·Filed 2009·Granted May 1, 2012·21 cites·13 claims
- 0692US9085629B2Compositions monovalent for CD28 binding and methods of useMCKINNON MURRAY·Filed 2012·Granted Jul 21, 2015·18 cites·29 claims
- 0791US10919965B2Compositions monovalent for CD28 binding and methods of useBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 16, 2021·3 cites·18 claims
- 0891US9475879B2Antibody polypeptides that antagonize CD40SURI ANISH·Filed 2012·Granted Oct 25, 2016·31 cites·15 claims
- 0991US9228018B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 5, 2016·11 cites·35 claims
- 1088US9908937B2Compositions monovalent for CD28 binding and methods of useBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Mar 6, 2018·5 cites·22 claims
- 1188US9765150B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 19, 2017·5 cites·37 claims
- 1288US8981072B2Nucleic acids encoding antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 17, 2015·8 cites·27 claims
- 1388US7358074B2Human phosphatase RET31, and variants thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Apr 15, 2008·14 cites·16 claims
- 1486US11267888B2Methods of treating systemic lupus erythematosus using a domain antibody directed against CD28BRISTOL MYERS SQUIBB CO·Filed 2020·Granted Mar 8, 2022·2 cites·6 claims
- 1584US10435475B2Method of using antibody polypeptides that antagonize CD40 to treat IBDBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 8, 2019·9 cites·16 claims
- 1680US7153678B2Polynucleotides encoding the novel human phosphatase, RET31, and variants thereofBRISTOL MYERS SQUIBB·Filed 2001·Granted Dec 26, 2006·15 cites·28 claims
- 1778US10196451B2Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40LBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 5, 2019·1 cites·20 claims
- 1878US2022073636A1Antibody polypeptides that antagonize cd40lBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1977US2023322941A1Antagonistic CD40 Monoclonal Antibodies and Uses ThereofBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 2076US12012452B2Compositions monovalent for CD28 binding and methods of useBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jun 18, 2024·0 cites·20 claims
- 2175US11466091B2Methods of treating autoimmune disease using a domain antibody directed against CD40LBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Oct 11, 2022·1 cites·16 claims
- 2273US11912769B2Methods of treating systemic lupus erythematosus using a domain antibody directed against CD28BRISTOL MYERS SQUIBB CO·Filed 2022·Granted Feb 27, 2024·0 cites·15 claims
- 2373US10544228B2Nucleic acids encoding antibody polypeptides that antagonize CD40BRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 28, 2020·1 cites·17 claims
- 2471US11180567B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 23, 2021·0 cites·20 claims
- 2571US2024241129A1Predictive peripheral blood biomarker for checkpoint inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 2666US2023295321A1Methods of treating autoimmune disease using a domain antibody directed against cd40lBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2764US11136406B2Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40BRISTOL MYERS SQUIBB CO·Filed 2019·Granted Oct 5, 2021·0 cites·20 claims
- 2858US11899017B2Predictive peripheral blood biomarker for checkpoint inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 13, 2024·0 cites·6 claims
- 2955US2020148779A1MODIFIED IgG1 Fc DOMAINS AND ANTI-CD40 DOMAIN ANTIBODY FUSIONS THEREWITHBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 3039US2017306034A1Methods of treating autoimmune disease using a domain antibody directed against cd40lBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 3138US2003130298A1Cd45 inhibitorsFiled 2000·Application pending·0 cites
- 3233US6939896B2Cd45 inhibitorsASTRAZENECA AB·Filed 2000·Granted Sep 6, 2005·0 cites·3 claims
- 3330US2003207812A1Cd45 inhibitorsFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Suzanne J. Suchard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →